Chelsea Campbell, MS

Chelsea Campbell is a PhD candidate in the Molecular Pathology and Immunology Program at Vanderbilt University. She obtained both her Bachelor of Science and Master of Science in Biology from Middle Tennessee State University before joining the laboratory of Dr. Elizabeth Phillips for her PhD studies. Her primary research interest aims to define the cellular and molecular mechanisms involved in the pathogenesis of HLA-B*58:01 restricted, allopurinol-associated Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN).